Tzong-Der Way

4PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 23, 2021
Bisdemethoxycurcumin Promotes Apoptosis and Inhibits the Epithelial-Mesenchymal Transition through the Inhibition of the G-Protein-Coupled Receptor 161/Mammalian Target of Rapamycin Signaling Pathway in Triple Negative Breast Cancer Cells.

Chun-Hung Chou, Hao-Kuang Wang, Ying-Chao Lin

|Oct 02, 2021
CSC-3436 sensitizes triple negative breast cancer cells to TRAIL-induced apoptosis through ROS-mediated p38/CHOP/death receptor 5 signaling pathways.

Chun-Chen Huang, Yi-Ching Cheng, Ying-Chao Lin

|Jul 22, 2021
Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway.

Chien-Chang Kao, Yi-Ching Cheng, Ming-Hsin Yang

|Nov 23, 2017
Pterostilbene Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors and Downregulation of Cell Survival Proteins in TRAIL-Resistance Triple Negative Breast Cancer Cells.

Chao-Ming Hung, Liang-Chih Liu, Chi-Tang Ho

Pageof 1

Frequent Collaborators

1 joint publications

Chi-Tang Ho